The effect of COVID-19 on Renal and Immuno-Suppressed Patients (C19-RISP)
C19-RISP aims to :
- Study the effect of COVID-19 in patients with renal disease (including dialysis patients) and immunosuppressed patients (including transplant recipients and patients with autoimmune disease);
- Investigate the immune response and pattern of inflammatory markers in these patient groups and compare them with healthy controls;
- Describe the clinical course and outcome of COVID-19 infection in patients with renal disease and immunosuppressed patients.
| Imperial PI | Dr Michelle Willicombe |
| Trial Sponsor | Imperial College London |
| Study type | Observational |
| Study status | In recruitment |